HSCS
HSCS
NASDAQ · Health Care

Heartsciences Inc

$1.81
-0.10 (-5.24%)
As of May 16, 2:31 AM ET ·
Financial Highlights (FY 2026)
Revenue
15.5K
Net Income
-31,395,194
Gross Margin
56.8%
Profit Margin
-201,499.5%
Rev Growth
-32.9%
D/E Ratio
12.43
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 56.8% 56.8% 46.4% 46.4%
Operating Margin -192,013.1% -172,813.7% 16.1% 16.8%
Profit Margin -201,499.5% -191,424.6% 17.0% 13.3%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 15.5K 23.0K 3.30M 3.40M
Gross Profit 8.8K 13.1K 1.53M 1.58M
Operating Income -29,681,384 -39,811,096 530.1K 570.8K
Net Income -31,395,194 -42,109,798 560.2K 453.4K
Gross Margin 56.8% 56.8% 46.4% 46.4%
Operating Margin -192,013.1% -172,813.7% 16.1% 16.8%
Profit Margin -201,499.5% -191,424.6% 17.0% 13.3%
Rev Growth -32.9% -32.9% +13.2% +5.1%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 2.82M 2.82M 3.60M 4.54M
Total Equity 226.4K 226.4K 4.32M 3.69M
D/E Ratio 12.43 12.43 0.83 1.23
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -29,468,198 -41,720,995 944.9K 908.1K
Free Cash Flow 381.1K 454.7K